BRIVIACT® (brivaracetam) IV– A Review of Selective SV2A Ligand & Associated Brain Permeability
Loading video
This video is currently being processed. It will be ready for viewing shortly.
Description
DESCRIPTION:
Dr. Brophy examines the mechanisms of action of select antiseizure medications,
with a focus on SV2A selectivity.
LEARNING
OBJECTIVES:
Understand how the mechanism of action and
pharmacokinetic profiles compare
Learn more about the discovery process of these
antiseizure medications
Understand the differences in affinity for SV2A,
lipophilicity, and brain permeability
FACULTY
Gretchen
Brophy, PharmD
Professor of
Pharmacotherapy & Outcomes Science and Neurosurgery
Virginia
Commonwealth University School of Pharmacy
Richmond,
Virginia